Britt Christensen (B Christensen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

Alimentary pharmacology & therapeutics

Inflammatory bowel diseases

Internal medicine journal

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Cathy Lu, Ryan Rosentreter, Maxime Delisle, Mattie White, Claire E Parker, Zahra Premji, Stephanie R Wilson, Mark E Baker, Gauraang Bhatnagar, Jacob Begun, David H Bruining, Robert Bryant, Britt Christensen, Brian G Feagan, Joel G Fletcher, Vipul Jairath, John Knudsen, Torsten Kucharzik, Christian Maaser, Giovanni Maconi, Kerri L Novak, Jordi Rimola, Stuart A Taylor, Rune Wilkens, Florian Rieders, null null
Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound. Alimentary pharmacology & therapeutics 59 (8) (2024)
Angharad Vernon-Roberts, Patrick P Y Chan, Britt Christensen, Rachael Havrlant, Edward M Giles, Astrid-Jane Williams
Pediatric to Adult Transition in Inflammatory Bowel Disease: Consensus Guidelines for Australia and New Zealand. Inflammatory bowel diseases (2024)
Patrick P Y Chan, Jack McNamara, Angharad Vernon-Roberts, Edward M Giles, Rachael Havrlant, Britt Christensen, Amanda Louise Thomas, Astrid-Jane Williams
Systematic Review: Practices and Programs in Inflammatory Bowel Disease Transition Care. Inflammatory bowel diseases (2024)
Noelle Rohatinsky, Sandra Zelinsky, Michael Todd Dolinger, Britt Christensen, Rune Wilkens, Shellie Jean Radford, Marla Dubinsky, Kerri L Novak
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study. Crohn's & colitis 360 5 (2) (2023)
Alexander Thomas Elford, Stephanie Dimovski, Britt Christensen
Tricks and traps of thioguanine: a case report of myelotoxicity. Internal medicine journal 53 (6) (2023)
Eva Zhang, Britt Christensen
Letter: ozanimod and latent tuberculosis-authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Eva Zhang, Britt Christensen
Letter: ozanimod and latent tuberculosis-authors' reply. Alimentary pharmacology & therapeutics 57 (3) (2023)
Noelle Rohatinsky, Sandra Zelinsky, Michael Todd Dolinger, Britt Christensen, Rune Wilkens, Shellie Jean Radford, Marla Dubinsky, Kerri L Novak
Crohn's Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study. Crohn's & colitis 360 5 (2) (2023)
Eva Zhang, Thi H O Nguyen, Lilith F Allen, Lukasz Kedzierski, Louise C Rowntree, So Young Chang, Wuji Zhang, Jennifer R Habel, Isabelle J Foo, Tejas Menon, Jeni Mitchell, Rupert W L Leong, Katherine Bond, Deborah A Williamson, Katherine Kedzierka, Britt Christensen
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments. Gut (2023)
Joëlle St-Pierre, Maxime Delisle, Hengameh Kheirkhahrahimabadi, Thomas M Goodsall, Robert V Bryant, Britt Christensen, Rose Vaughan, Aysha H Al-Ani, Richard J M Ingram, Joan Heatherington, Dan Carter, Cathy Lu, Christopher Ma, Kerri L Novak
Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization. Crohn's & colitis 360 5 (4) (2023)
Robyn Laube, Christian Philipp Selinger, Cynthia H-T Seow, Britt Christensen, Emma K Flanagan, Debra Kennedy, Reme Mountifield, Sean K M Seeho, Antonia W Shand, Astrid-Jane Williams, Rupert W L Leong
Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding. Gut (2023)
Roger Feakins, Paulo Borralho Nunes, Ann Driessen, Ilyssa O Gordon, Nina Zidar, Pamela Baldin, Britt Christensen, Silvio Danese, Naoimh Herlihy, Marietta Iacucci, Maurice B Loughrey, Fernando Magro, Aart Mookhoek, Magali Svrcek, Francesca Rosini
Definitions of histological abnormalities in inflammatory bowel disease: an ECCO position paper. Journal of Crohn's & colitis (2023)
Rose Vaughan, Elise Murphy, Michelle Nalder, Robert N Gibson, Zaid S Ardalan, Alex Boussioutas, Britt Christensen
Infliximab Trough Levels Are Associated With Transmural Sonographic Healing in Inflammatory Bowel Disease. Inflammatory bowel diseases (2022)
Britt Christensen, Ralley E Prentice, Aysha H Al-Ani, Eva Zhang, Alyse Bedell, David T Rubin
Self-Reported Failure to Address Sexual Function in Patients With Inflammatory Bowel Disease by Gastroenterologists: Barriers and Areas for Improvement. Inflammatory bowel diseases 28 (9) (2022)
Sasha R Fehily, Aysha H Al-Ani, Jonathan Abdelmalak, Clarissa Rentch, Eva Zhang, Justin T Denholm, Douglas Johnson, William K K Wu, Navneet Sharma, David T Rubin, Peter R Gibson, Britt Christensen
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and management. Alimentary pharmacology & therapeutics 56 (1) (2022)
Eva Zhang, Arun Gupta, Aysha H Al-Ani, Finlay A Macrae, Rupert W L Leong, Britt Christensen
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease. Canadian journal of gastroenterology & hepatology 2022 (2022)
Emma K Flanagan, Emily K Wright, Miles P Sparrow, Gregory T Moore, William R Connell, Peter De Cruz, Britt Christensen, Edward Shelton, Michael A Kamm, Mark G Ward, Damian Dowling, Steven Brown, Soleiman Kashkooli, Alexander J Thompson, Alyson L Ross, Katerina V Kiburg, Sally J Bell
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflammatory bowel diseases 27 (12) (2022)
Rose Vaughan, Douglas Tjandra, Ashwin Patwardhan, Nicholas Mingos, Robert Gibson, Alex Boussioutas, Zaid S Ardalan, Aysha Al-Ani, Peter R Gibson, Britt Christensen
Toward transmural healing: Sonographic healing is associated with improved long-term outcomes in patients with Crohn's disease. Alimentary pharmacology & therapeutics 56 (1) (2022)
Aysha H Al-Ani, Ralley E Prentice, Clarissa Rentsch, Britt Christensen
Letter: SARS-CoV-2 infection in two inflammatory bowel disease patients treated with dual targeted therapy-Authors' reply. Alimentary pharmacology & therapeutics 53 (6) (2021)
Johan F K F Ilvemark, Tawnya Hansen, Thomas M Goodsall, Jakob B Seidelin, Heba Al-Farhan, Mariangela Allocca, Jacob Begun, Robert V Bryant, Dan Carter, Britt Christensen, Marla C Dubinsky, Krisztina B Gecse, Torsten Kucharzik, Cathy Lu, Christian Maaser, Giovanni Maconi, Kim Nylund, Carolina Palmela, Stephanie R Wilson, Kerri Novak, Rune Wilkens
Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement. Journal of Crohn's & colitis (2021)
Seth R Shaffer, Amarachi I Erondu, Cindy Traboulsi, Victoria Rai, Noa Krugliak Cleveland, Amanda Israel, Britt Christensen, David T Rubin
Achieving Histologic Normalization in Ulcerative Colitis Is Associated With a Reduced Risk of Subsequent Dysplasia. Inflammatory bowel diseases (2021)
Andrew D Buckle, Britt Christensen
Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy-checkpoint inhibitor colitis. Alimentary pharmacology & therapeutics 53 (5) (2021)
Gurpreet Singh, Ralley Prentice, David Langsford, Britt Christensen, Mayur Garg
Altered bowel habit and rectal bleeding in pregnancy: the importance of recognising undiagnosed inflammatory bowel disease. Internal medicine journal 51 (3) (2021)
Ralley E Prentice, Aysha H Al-Ani, Britt Christensen
Managing COVID-19 in patients with inflammatory bowel disease: navigating unprecedented challenges. Internal medicine journal 51 (2) (2021)
Douglas Tjandra, Mayur Garg, Cori Behrenbruch, Jacob McCormick, Paul Simkin, Ralley E Prentice, Andrew Trinh, Aysha H Al-Ani, Rose Vaughan, Finlay Macrae, Britt Christensen
Review article: investigation and management of internal fistulae in Crohn's disease. Alimentary pharmacology & therapeutics 53 (10) (2021)
Ralley E Prentice, Clarissa Rentsch, Aysha H Al-Ani, Eva Zhang, Douglas Johnson, John Halliday, Robert V Bryant, Jacob Begun, Mark G Ward, Peter J Lewindon, Susan J Connor, Simon Ghaly, Britt Christensen
SARS-CoV-2 vaccination in patients with inflammatory bowel disease. GastroHep 3 (4) (2021)
Thomas M Goodsall, Vipul Jairath, Brian G Feagan, Claire E Parker, Tran M Nguyen, Leonardo Guizzetti, Anil K Asthana, Jakob Begun, Britt Christensen, Antony B Friedman, Torsten Kucharzik, Andrew Lee, Peter J Lewindon, Christian Maaser, Kerri L Novak, Jordi Rimola, Kirstin M Taylor, Stuart A Taylor, Lauren S White, Rune Wilkens, Stephanie R Wilson, Emily K Wright, Robert V Bryant, Christopher Ma
Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn's disease. Alimentary pharmacology & therapeutics 53 (8) (2021)
Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, Doug Johnson, Zaid S Ardalan, Neel M Heerasing, Mayur Garg, Sian Campbell, Joe Sasadeusz, Finlay A Macrae, William K K Wu, David T Rubin, Britt Christensen
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Alimentary pharmacology & therapeutics 52 (1) (2020)
Al-Ani Aysha, Clarissa Rentsch, Ralley Prentice, Doug Johnson, Robert V Bryant, Mark G Ward, Samuel Paul Costello, Peter Lewindon, Simon Ghaly, Susan J Connor, Jakob Begun, Britt Christensen
Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Internal medicine journal 50 (7) (2020)
Emma K Flanagan, Peter R Gibson, Emily K Wright, Gregory T Moore, Miles Patrick Sparrow, William Connell, Michael A Kamm, Jakob Begun, Britt Christensen, Peter De Cruz, Edward Shelton, Damian Dowling, Jane M Andrews, Steven J Brown, Olga D Niewiadomski, Mark G Ward, Ourania Rosella, Gennaro Rosella, Katerina V Kiburg, Alyson L Ross, Sally J Bell, null null
Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary pharmacology & therapeutics 52 (10) (2020)
Ralley E Prentice, Douglas Tjandra, Mayur Garg, John S Lubel, Spiros Fourlanos, Doug Johnson, Aysha Al-Ani, Britt Christensen
Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19. Alimentary pharmacology & therapeutics 52 (8) (2020)
Mayur Garg, Aysha Al-Ani, Hannah Mitchell, Philip Hendy, Britt Christensen
Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North-supports vitamin D as a factor determining severity. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Aysha H Al-Ani, Clarissa A Rentsch, Sofia Azim, Emma Bidgood, Princy Onasseril, Britt Christensen
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply. Alimentary pharmacology & therapeutics 52 (4) (2020)
Ralley E Prentice, Aysha H Al-Ani, Britt Christensen
Letter: Covid-19-re-initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply. Alimentary pharmacology & therapeutics 52 (8) (2020)
Britt Christensen, P R Gibson, D T Rubin
Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply. Alimentary pharmacology & therapeutics 47 (10) (2019)
Jacob E Ollech, Sujaata Dwadasi, Victoria Rai, Noam Peleg, Inessa Normatov, Amanda Israel, Philip H Sossenheimer, Britt Christensen, Joel Pekow, Sushila R Dalal, Atsushi Sakuraba, Russell D Cohen, David T Rubin
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis. Alimentary pharmacology & therapeutics 51 (6) (2019)
Britt Christensen, D Micic, P R Gibson, A Yarur, E Bellaguarda, P Corsello, J N Gaetano, J Kinnucan, V L Rao, S Reddy, S Singh, J Pekow, D T Rubin
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. Alimentary pharmacology & therapeutics 47 (6) (2018)